Heinrich Taegtmeyer, MD
See Publications

Texas Heart Institute Positions

  • Co-Director, Internal Medicine

Interests

  • Heart failure
  • Diabetes
  • Obesity
  • Consultative
  • Outpatient cardiology Electrocardiography

Education

  • Undergraduate:

    University of Freiburg , Germany

  • Postgraduate:

    University Hospitals of Freiburg, Germany

  • Medical School:

    Albert-Ludwigs Universitat Freiburg

  • Residency:

    Boston City Hospital

  • Fellowships:

    Peter Bent Brigham Hospital

Academic & Clinical Affiliations

  • Baylor College of Medicine
  • Memorial Hermann
  • The University of Texas Health Science Center at Houston
  • UT Physicians

Certifications

  • Medizinisches Staatsexamen (Germany)
  • Approbation als Arzt (Germany)
  • American Board of Internal Medicine
  • American Board of Internal Medicine – Cardiovascular Diseases

Honors, Awards and Memberships

  • American College of Cardiology
  • American College of Physicians
  • American Heart Association
  • Chair, writing group for the American Heart Association Scientific Statement on Assess Cardiac Metabolism (2016)
  • Gold Humanism in Medicine Honor Society (2015)
  • Leonard Tow Humanism in Medicine Award, McGovern Medical School (2015)
  • President’s Scholar Award for Research, The University of Texas Health Science Center at Houston (2016)
  • The Texas Heart Institute Academic Professional Staff

Publications

4862227 9DBYXNEE 1 alternatives-to-animal-experimentation 10 date desc Taegtmeyer 2125 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22PMR7VPMP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Taegtmeyer%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%2C%20H.%2C%20Ganim%2C%20J.%20and%20Leuppi-%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20B.%20%282023%29.%20Hermann%20%28%26%23x201C%3BHugh%26%23x201D%3B%29%20Blaschko%20%281900%20-%201993%29%20father%20of%20catecholamine%20metabolism.%20%26lt%3Bi%26gt%3BCardiology%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000528895%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000528895%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hermann%20%28%5C%22Hugh%5C%22%29%20Blaschko%20%281900%20-%201993%29%20father%20of%20catecholamine%20metabolism%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiries%22%2C%22lastName%22%3A%22Ganim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Barbara%22%2C%22lastName%22%3A%22Leuppi-Taegtmeyer%22%7D%5D%2C%22abstractNote%22%3A%22Among%20the%20architects%20of%20metabolic%20pathways%2C%20the%20names%20Knoop%2C%20Warburg%2C%20Meyerhof%2C%20and%20Krebs%20are%20well%20known.%20Here%20we%20focus%20on%20Hermann%20%26quot%3BHugh%26quot%3B%20Blaschko%2C%20whose%20name%20may%20be%20less%20well%20known%2C%20but%20whose%20work%20on%20the%20synthesis%20and%20degradation%20of%20catecholamines%20set%20the%20foundation%20for%20countless%2C%20game-changing%20therapeutics%20throughout%20the%2020th%20and%2021st%20centuries.%22%2C%22date%22%3A%22Jan%2004%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1159%5C%2F000528895%22%2C%22ISSN%22%3A%221421-9751%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%2C%22FA6KSIY7%22%5D%2C%22dateModified%22%3A%222023-02-14T20%3A18%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22HBETLDJI%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gutierrez%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGutierrez%2C%20A.%20D.%2C%20Gao%2C%20Z.%2C%20Hamidi%2C%20V.%20et%20al.%20%282022%29.%20Anti-diabetic%20effects%20of%20GLP1%20analogs%20are%20mediated%20by%20thermogenic%20interleukin-6%20signaling%20in%20adipocytes.%20%26lt%3Bi%26gt%3BCell%20Rep%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B3%26lt%3B%5C%2Fi%26gt%3B%2C%20100813.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xcrm.2022.100813%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xcrm.2022.100813%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Anti-diabetic%20effects%20of%20GLP1%20analogs%20are%20mediated%20by%20thermogenic%20interleukin-6%20signaling%20in%20adipocytes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Absalon%20D.%22%2C%22lastName%22%3A%22Gutierrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanguo%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vala%22%2C%22lastName%22%3A%22Hamidi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liang%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karla%20Bermudez%22%2C%22lastName%22%3A%22Saint%20Andre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kayla%22%2C%22lastName%22%3A%22Riggs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monika%22%2C%22lastName%22%3A%22Ruscheinsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongyu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yongmei%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hernan%22%2C%22lastName%22%3A%22Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikhail%20G.%22%2C%22lastName%22%3A%22Kolonin%22%7D%5D%2C%22abstractNote%22%3A%22Mechanisms%20underlying%20anti-diabetic%20effects%20of%20GLP1%20analogs%20remain%20incompletely%20understood.%20We%20observed%20that%20in%20prediabetic%20humans%20exenatide%20treatment%20acutely%20induces%20interleukin-6%20%28IL-6%29%20secretion%20by%20monocytes%20and%20IL-6%20in%20systemic%20circulation.%20We%20hypothesized%20that%20GLP1%20analogs%20signal%20through%20IL-6%20in%20adipose%20tissue%20%28AT%29%20and%20used%20the%20mouse%20model%20to%20test%20if%20IL-6%20receptor%20%28IL-6R%29%20signaling%20underlies%20the%20effects%20of%20the%20GLP1-IL-6%20axis.%20We%20show%20that%20liraglutide%20transiently%20increases%20IL-6%20in%20mouse%20circulation%20and%20IL-6R%20signaling%20in%20AT.%20Metronomic%20liraglutide%20treatment%20resulted%20in%20AT%20browning%20and%20thermogenesis%20linked%20with%20STAT3%20activation.%20IL-6-blocking%20antibody%20treatment%20inhibited%20STAT3%20activation%20in%20AT%20and%20suppressed%20liraglutide-induced%20increase%20in%20thermogenesis%20and%20glucose%20utilization.%20We%20show%20that%20adipose%20IL-6R%20knockout%20mice%20still%20display%20liraglutide-induced%20weight%20loss%20but%20lack%20thermogenic%20adipocyte%20browning%20and%20metabolism%20activation.%20We%20conclude%20that%20the%20anti-diabetic%20effects%20of%20GLP1%20analogs%20are%20mediated%20by%20transient%20upregulation%20of%20IL-6%2C%20which%20activates%20canonical%20IL-6R%20signaling%20and%20thermogenesis.%22%2C%22date%22%3A%22Nov%2015%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xcrm.2022.100813%22%2C%22ISSN%22%3A%222666-3791%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IJQY3WXE%22%2C%229DBYXNEE%22%2C%22TXW6RMW4%22%5D%2C%22dateModified%22%3A%222023-01-06T17%3A12%3A06Z%22%7D%7D%2C%7B%22key%22%3A%2224ZZ7AJ2%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ashraf%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAshraf%2C%20S.%2C%20%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%2C%20H.%20and%20Harmancey%2C%20R.%20%282022%29.%20Prolonged%20cardiac%20NR4A2%20activation%20causes%20dilated%20cardiomyopathy%20in%20mice.%20%26lt%3Bi%26gt%3BBasic%20Res%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B117%26lt%3B%5C%2Fi%26gt%3B%2C%2033.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00395-022-00942-7%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00395-022-00942-7%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prolonged%20cardiac%20NR4A2%20activation%20causes%20dilated%20cardiomyopathy%20in%20mice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sadia%22%2C%22lastName%22%3A%22Ashraf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Harmancey%22%7D%5D%2C%22abstractNote%22%3A%22Transcription%20factors%20play%20a%20fundamental%20role%20in%20cardiovascular%20adaptation%20to%20stress.%20Nuclear%20receptor%20subfamily%204%20group%20A%20member%202%20%28NR4A2%3B%20NURR1%29%20is%20an%20immediate-early%20gene%20and%20transcription%20factor%20with%20a%20versatile%20role%20throughout%20many%20organs.%20In%20the%20adult%20mammalian%20heart%2C%20and%20particularly%20in%20cardiac%20myocytes%2C%20NR4A2%20is%20strongly%20up-regulated%20in%20response%20to%20beta-adrenergic%20stimulation.%20The%20physiologic%20implications%20of%20this%20increase%20remain%20unknown.%20In%20this%20study%2C%20we%20aimed%20to%20interrogate%20the%20consequences%20of%20cardiac%20NR4A2%20up-regulation%20under%20normal%20conditions%20and%20in%20response%20to%20pressure%20overload.%20In%20mice%2C%20tamoxifen-dependent%2C%20cardiomyocyte-restricted%20overexpression%20of%20NR4A2%20led%20to%20cardiomyocyte%20hypertrophy%2C%20left%20ventricular%20dilation%2C%20heart%20failure%2C%20and%20death%20within%2040%5Cu00a0days.%20Chronic%20NR4A2%20induction%20also%20precipitated%20cardiac%20decompensation%20during%20transverse%20aortic%20constriction%20%28TAC%29-induced%20pressure%20overload.%20Mechanistically%2C%20NR4A2%20caused%20adult%20cardiac%20myocytes%20to%20return%20to%20a%20fetal-like%20phenotype%2C%20with%20a%20switch%20to%20glycolytic%20metabolism%20and%20disassembly%20of%20sarcomeric%20structures.%20NR4A2%20also%20re-activated%20cell%20cycle%20progression%20and%20stimulated%20DNA%20replication%20and%20karyokinesis%20but%20failed%20to%20induce%20cytokinesis%2C%20thereby%20promoting%20multinucleation%20of%20cardiac%20myocytes.%20Activation%20of%20cell%20cycle%20checkpoints%20led%20to%20induction%20of%20an%20apoptotic%20response%20which%20ultimately%20resulted%20in%20excessive%20loss%20of%20cardiac%20myocytes%20and%20impaired%20left%20ventricular%20contractile%20function.%20In%20summary%2C%20myocyte-specific%20overexpression%20of%20NR4A2%20in%20the%20postnatal%20mammalian%20heart%20results%20in%20increased%20cell%20cycle%20re-entry%20and%20DNA%20replication%20but%20does%20not%20result%20in%20cardiac%20myocyte%20division.%20Our%20findings%20expose%20a%20novel%20function%20for%20the%20nuclear%20receptor%20as%20a%20critical%20regulator%20in%20the%20self-renewal%20of%20the%20cardiac%20myocyte%20and%20heart%20regeneration.%22%2C%22date%22%3A%22July%2001%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00395-022-00942-7%22%2C%22ISSN%22%3A%221435-1803%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%2C%222RCWVZ4F%22%5D%2C%22dateModified%22%3A%222022-08-02T14%3A42%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22GRCU2EB4%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Karlstaedt%20and%20Taegtmeyer%22%2C%22parsedDate%22%3A%222022-06-28%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKarlstaedt%2C%20A.%20and%20%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%2C%20H.%20%282022%29.%20Cardio-onco-metabolism%20-%20metabolic%20vulnerabilities%20in%20cancer%20and%20the%20heart.%20%26lt%3Bi%26gt%3BJ%20Mol%20Cell%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B171%26lt%3B%5C%2Fi%26gt%3B%2C%2071%26%23x2013%3B80.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.yjmcc.2022.06.008%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.yjmcc.2022.06.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardio-onco-metabolism%20-%20metabolic%20vulnerabilities%20in%20cancer%20and%20the%20heart%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anja%22%2C%22lastName%22%3A%22Karlstaedt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%5D%2C%22abstractNote%22%3A%22Cancer%20and%20cardiovascular%20diseases%20%28CVDs%29%20are%20the%20leading%20cause%20of%20death%20worldwide.%20Metabolic%20remodeling%20is%20a%20hallmark%20of%20both%20cancer%20and%20the%20failing%20heart.%20Tumors%20reprogram%20metabolism%20to%20optimize%20nutrient%20utilization%20and%20meet%20increased%20demands%20for%20energy%20provision%2C%20biosynthetic%20pathways%2C%20and%20proliferation.%20Shared%20risk%20factors%20for%20cancer%20and%20CVDs%20suggest%20intersecting%20mechanisms%20for%20disease%20pathogenesis%20and%20progression.%20In%20this%20review%2C%20we%20aim%20to%20highlight%20the%20role%20of%20metabolic%20remodeling%20in%20cancer%20and%20its%20potential%20to%20impair%20cardiac%20function.%20Understanding%20these%20mechanisms%20will%20help%20us%20develop%20biomarkers%2C%20better%20therapies%2C%20and%20identify%20patients%20at%20risk%20of%20developing%20heart%20disease%20after%20surviving%20cancer.%22%2C%22date%22%3A%22June%2028%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.yjmcc.2022.06.008%22%2C%22ISSN%22%3A%221095-8584%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%2C%222RCWVZ4F%22%5D%2C%22dateModified%22%3A%222022-08-02T14%3A39%3A23Z%22%7D%7D%2C%7B%22key%22%3A%224DF9QC8Y%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Thomas%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BThomas%2C%20S.%20S.%2C%20Wu%2C%20J.%2C%20Davogustto%2C%20G.%20et%20al.%20%282022%29.%20SIRP%26%23x3B1%3B%20mediates%20IGF1%20receptor%20in%20cardiomyopathy-induced%20by%20chronic%20kidney%20disease.%20%26lt%3Bi%26gt%3BCirc%20Res%26lt%3B%5C%2Fi%26gt%3B%2C%20101161CIRCRESAHA121320546.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCRESAHA.121.320546%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCRESAHA.121.320546%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22SIRP%5Cu03b1%20mediates%20IGF1%20receptor%20in%20cardiomyopathy-induced%20by%20chronic%20kidney%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandhya%20S.%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiao%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Davogustto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20W.%22%2C%22lastName%22%3A%22Holliday%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristen%22%2C%22lastName%22%3A%22Eckel-Mahan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Verzola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giacomo%22%2C%22lastName%22%3A%22Garibotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhaoyong%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20E.%22%2C%22lastName%22%3A%22Mitch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Chronic%20kidney%20disease%20%28CKD%29%20is%20characterized%20by%20increased%20myocardial%20mass%20despite%20near-normal%20blood%20pressure%2C%20suggesting%20the%20presence%20of%20a%20separate%20trigger.%20A%20potential%20driver%20is%20SIRP%5Cu03b1%20%28signal%20regulatory%20protein%20alpha%29-a%20mediator%20impairing%20insulin%20signaling.%20The%20objective%20of%20this%20study%20is%20to%20assess%20the%20role%20of%20circulating%20SIRP%5Cu03b1%20in%20CKD-induced%20adverse%20cardiac%20remodeling.%5CnMETHODS%3A%20SIRP%5Cu03b1%20expression%20was%20evaluated%20in%20mouse%20models%20and%20patients%20with%20CKD.%20Specifically%2C%20mutant%2C%20muscle-specific%2C%20or%20cardiac%20muscle-specific%20SIRP%5Cu03b1%20KO%20%28knockout%29%20mice%20were%20examined%20after%20subtotal%20nephrectomy.%20Cardiac%20function%20was%20assessed%20by%20echocardiography.%20Metabolic%20responses%20were%20confirmed%20in%20cultured%20muscle%20cells%20or%20cardiomyocytes.%5CnRESULTS%3A%20We%20demonstrate%20that%20SIRP%5Cu03b1%20regulates%20myocardial%20insulin%5C%2FIGF1R%20%28insulin%20growth%20factor-1%20receptor%29%20signaling%20in%20CKD.%20First%2C%20in%20the%20serum%20of%20both%20mice%20and%20patients%2C%20SIRP%5Cu03b1%20was%20robustly%20secreted%20in%20response%20to%20CKD.%20Second%2C%20cardiac%20muscle%20upregulation%20of%20SIRP%5Cu03b1%20was%20associated%20with%20impaired%20insulin%5C%2FIGF1R%20signaling%2C%20myocardial%20dysfunction%2C%20and%20fibrosis.%20However%2C%20both%20global%20and%20cardiac%20muscle-specific%20SIRP%5Cu03b1%20KO%20mice%20displayed%20improved%20cardiac%20function%20when%20compared%20with%20control%20mice%20with%20CKD.%20Third%2C%20both%20muscle-specific%20or%20cardiac%20muscle-specific%20SIRP%5Cu03b1%20KO%20mice%20did%20not%20significantly%20activate%20fetal%20genes%20and%20maintained%20insulin%5C%2FIGF1R%20signaling%20with%20suppressed%20fibrosis%20despite%20the%20presence%20of%20CKD.%20Importantly%2C%20SIRP%5Cu03b1%20directly%20interacted%20with%20IGF1R.%20Next%2C%20rSIRP%5Cu03b1%20%28recombinant%20SIRP%5Cu03b1%29%20protein%20was%20introduced%20into%20mSIRP%5Cu03b1%20KO%20mice%20reestablishing%20the%20insulin%5C%2FIGF1R%20signaling%20activity.%20Additionally%2C%20overexpression%20of%20SIRP%5Cu03b1%20in%20myoblasts%20and%20cardiomyocytes%20impaired%20pAKT%20and%20insulin%5C%2FIGF1R%20signaling.%20Furthermore%2C%20myotubes%20and%20cardiomyocytes%2C%20but%20not%20adipocytes%20treated%20with%20high%20glucose%20or%20cardiomyocytes%20treated%20with%20uremic%20toxins%2C%20stimulated%20secretion%20of%20SIRP%5Cu03b1%20in%20culture%20media%2C%20suggesting%20these%20cells%20are%20the%20origin%20of%20circulating%20SIRP%5Cu03b1%20in%20CKD.%20Both%20intracellular%20and%20extracellular%20SIRP%5Cu03b1%20exert%20biologically%20synergistic%20effects%20impairing%20intracellular%20myocardial%20insulin%5C%2FIGF1R%20signaling.%5CnCONCLUSIONS%3A%20Myokine%20SIRP%5Cu03b1%20expression%20impairs%20insulin%5C%2FIGF1R%20functions%20in%20cardiac%20muscle%2C%20affecting%20cardiometabolic%20signaling%20pathways.%20Circulating%20SIRP%5Cu03b1%20constitutes%20an%20important%20readout%20of%20insulin%20resistance%20in%20CKD-induced%20cardiomyopathy.%22%2C%22date%22%3A%22June%2020%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCRESAHA.121.320546%22%2C%22ISSN%22%3A%221524-4571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%2C%22ZSY78DJL%22%5D%2C%22dateModified%22%3A%222022-07-06T19%3A09%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22LDK45L9L%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Taegtmeyer%20et%20al.%22%2C%22parsedDate%22%3A%222022-05-24%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%2C%20H.%2C%20Zaha%2C%20V.%20G.%20and%20McGuire%2C%20D.%20K.%20%282022%29.%202022%20Beijing%20Winter%20Olympics%3A%20Spotlight%20on%20cardiac%20metabolism.%20%26lt%3Bi%26gt%3BCirculation%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B145%26lt%3B%5C%2Fi%26gt%3B%2C%201561%26%23x2013%3B1562.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.122.059905%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.122.059905%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%222022%20Beijing%20Winter%20Olympics%3A%20Spotlight%20on%20cardiac%20metabolism%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vlad%20G.%22%2C%22lastName%22%3A%22Zaha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20K.%22%2C%22lastName%22%3A%22McGuire%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22May%2024%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCULATIONAHA.122.059905%22%2C%22ISSN%22%3A%221524-4539%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%2C%22V4E2TPM3%22%5D%2C%22dateModified%22%3A%222022-05-27T19%3A08%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22Z729UQXC%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Huang%20Lucas%20and%20Taegtmeyer%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHuang%20Lucas%2C%20C.%20and%20%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%2C%20H.%20%282022%29.%20Letter%20by%20Lucas%20and%20%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%20regarding%20article%2C%20%26%23x201C%3BOne-Year%20Committed%20Exercise%20Training%20Reverses%20Abnormal%20Left%20Ventricular%20Myocardial%20Stiffness%20in%20Patients%20With%20Stage%20B%20Heart%20Failure%20With%20Preserved%20Ejection%20Fraction.%26%23x201D%3B%20%26lt%3Bi%26gt%3BCirculation%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B145%26lt%3B%5C%2Fi%26gt%3B%2C%20e642%26%23x2013%3Be643.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.121.058145%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.121.058145%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Letter%20by%20Lucas%20and%20Taegtmeyer%20regarding%20article%2C%20%5C%22One-Year%20Committed%20Exercise%20Training%20Reverses%20Abnormal%20Left%20Ventricular%20Myocardial%20Stiffness%20in%20Patients%20With%20Stage%20B%20Heart%20Failure%20With%20Preserved%20Ejection%20Fraction%5C%22%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Huang%20Lucas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Mar%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCULATIONAHA.121.058145%22%2C%22ISSN%22%3A%221524-4539%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%2C%22LNSKD4V3%22%5D%2C%22dateModified%22%3A%222022-03-29T18%3A43%3A35Z%22%7D%7D%2C%7B%22key%22%3A%226TBNCZR9%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Haidar%20and%20Taegtmeyer%22%2C%22parsedDate%22%3A%222022-02-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHaidar%2C%20A.%20and%20%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%2C%20H.%20%282022%29.%20Strategies%20for%20imaging%20metabolic%20remodeling%20of%20the%20heart%20in%20obesity%20and%20heart%20failure.%20%26lt%3Bi%26gt%3BCurr%20Cardiol%20Rep%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11886-022-01650-3%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11886-022-01650-3%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Strategies%20for%20imaging%20metabolic%20remodeling%20of%20the%20heart%20in%20obesity%20and%20heart%20failure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amier%22%2C%22lastName%22%3A%22Haidar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%20OF%20REVIEW%3A%20Define%20early%20myocardial%20metabolic%20changes%20among%20patients%20with%20obesity%20and%20heart%20failure%2C%20and%20to%20describe%20noninvasive%20methods%20and%20their%20applications%20for%20imaging%20cardiac%20metabolic%20remodeling.%5CnRECENT%20FINDINGS%3A%20Metabolic%20remodeling%20precedes%2C%20triggers%2C%20and%20sustains%20functional%20and%20structural%20remodeling%20in%20the%20stressed%20heart.%20Alterations%20in%20cardiac%20metabolism%20can%20be%20assessed%20by%20using%20a%20variety%20of%20molecular%20probes.%20The%20glucose%20tracer%20analog%2C%2018F-FDG%2C%20and%20the%20labeled%20tracer%2011C-palmitate%20are%20still%20the%20most%20commonly%20used%20tracers%20to%20assess%20glucose%20and%20fatty%20acid%20metabolism%2C%20respectively.%20The%20development%20of%20new%20tracer%20analogs%20and%20imaging%20agents%2C%20including%20those%20targeting%20the%20peroxisome%20proliferator-activated%20receptor%20%28PPAR%29%2C%20provides%20new%20opportunities%20for%20imaging%20metabolic%20activities%20at%20a%20molecular%20level.%20While%20the%20use%20of%20cardiac%20magnetic%20resonance%20spectroscopy%20in%20the%20clinical%20setting%20is%20limited%20to%20the%20assessment%20of%20intramyocardial%20and%20epicardial%20fat%2C%20new%20technical%20improvements%20are%20likely%20to%20increase%20its%20usage%20in%20the%20setting%20of%20heart%20failure.%20Noninvasive%20imaging%20methods%20are%20an%20effective%20tool%20for%20the%20serial%20assessment%20of%20alterations%20in%20cardiac%20metabolism%2C%20either%20during%20disease%20progression%2C%20or%20in%20response%20to%20treatment.%22%2C%22date%22%3A%22Feb%2002%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11886-022-01650-3%22%2C%22ISSN%22%3A%221534-3170%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%2C%22WC4XX237%22%5D%2C%22dateModified%22%3A%222022-02-25T20%3A25%3A19Z%22%7D%7D%2C%7B%22key%22%3A%229ITABPST%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Farr%22%2C%22parsedDate%22%3A%222021-11-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFarr%2C%20M.%20%282021%29.%20A%20foot%20soldier%20in%20cardiac%20metabolism%3A%20A%20conversation%20with%20Heinrich%20%26lt%3Bstrong%26gt%3BTaegtmeyer%26lt%3B%5C%2Fstrong%26gt%3B%2C%20MD%2C%20DPhil.%20%26lt%3Bi%26gt%3BCirculation%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B144%26lt%3B%5C%2Fi%26gt%3B%2C%201659%26%23x2013%3B1663.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.121.058019%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.121.058019%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20foot%20soldier%20in%20cardiac%20metabolism%3A%20A%20conversation%20with%20Heinrich%20Taegtmeyer%2C%20MD%2C%20DPhil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryjane%22%2C%22lastName%22%3A%22Farr%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Nov%2023%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCULATIONAHA.121.058019%22%2C%22ISSN%22%3A%221524-4539%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%5D%2C%22dateModified%22%3A%222021-12-06T20%3A54%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22SLF6KZVT%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Davogustto%20et%20al.%22%2C%22parsedDate%22%3A%222021-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDavogustto%2C%20G.%20E.%2C%20Salazar%2C%20R.%20L.%2C%20Vasquez%2C%20H.%20G.%20et%20al.%20%282021%29.%20Metabolic%20remodeling%20precedes%20mTORC1-mediated%20cardiac%20hypertrophy.%20%26lt%3Bi%26gt%3BJ%20Mol%20Cell%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B158%26lt%3B%5C%2Fi%26gt%3B%2C%20115%26%23x2013%3B127.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.yjmcc.2021.05.016%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.yjmcc.2021.05.016%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Metabolic%20remodeling%20precedes%20mTORC1-mediated%20cardiac%20hypertrophy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%20E.%22%2C%22lastName%22%3A%22Davogustto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20L.%22%2C%22lastName%22%3A%22Salazar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hernan%20G.%22%2C%22lastName%22%3A%22Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anja%22%2C%22lastName%22%3A%22Karlstaedt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20P.%22%2C%22lastName%22%3A%22Dillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20H.%22%2C%22lastName%22%3A%22Guthrie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20R.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%22%2C%22lastName%22%3A%22Vitrac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gina%22%2C%22lastName%22%3A%22De%20La%20Guardia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Vela%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleix%22%2C%22lastName%22%3A%22Ribas-Latre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corrine%22%2C%22lastName%22%3A%22Baumgartner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristin%22%2C%22lastName%22%3A%22Eckel-Mahan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Taegtmeyer%22%7D%5D%2C%22abstractNote%22%3A%22RATIONALE%3A%20The%20nutrient%20sensing%20mechanistic%20target%20of%20rapamycin%20complex%201%20%28mTORC1%29%20and%20its%20primary%20inhibitor%2C%20tuberin%20%28TSC2%29%2C%20are%20cues%20for%20the%20development%20of%20cardiac%20hypertrophy.%20The%20phenotype%20of%20mTORC1%20induced%20hypertrophy%20is%20unknown.%5CnOBJECTIVE%3A%20To%20examine%20the%20impact%20of%20sustained%20mTORC1%20activation%20on%20metabolism%2C%20function%2C%20and%20structure%20of%20the%20adult%20heart.%5CnMETHODS%20AND%20RESULTS%3A%20We%20developed%20a%20mouse%20model%20of%20inducible%2C%20cardiac-specific%20sustained%20mTORC1%20activation%20%28mTORC1iSA%29%20through%20deletion%20of%20Tsc2.%20Prior%20to%20hypertrophy%2C%20rates%20of%20glucose%20uptake%20and%20oxidation%2C%20as%20well%20as%20protein%20and%20enzymatic%20activity%20of%20glucose%206-phosphate%20isomerase%20%28GPI%29%20were%20decreased%2C%20while%20intracellular%20levels%20of%20glucose%206-phosphate%20%28G6P%29%20were%20increased.%20Subsequently%2C%20hypertrophy%20developed.%20Transcript%20levels%20of%20the%20fetal%20gene%20program%20and%20pathways%20of%20exercise-induced%20hypertrophy%20increased%2C%20while%20hypertrophy%20did%20not%20progress%20to%20heart%20failure.%20We%20therefore%20examined%20the%20hearts%20of%20wild-type%20mice%20subjected%20to%20voluntary%20physical%20activity%20and%20observed%20early%20changes%20in%20GPI%2C%20followed%20by%20hypertrophy.%20Rapamycin%20prevented%20these%20changes%20in%20both%20models.%5CnCONCLUSION%3A%20Activation%20of%20mTORC1%20in%20the%20adult%20heart%20triggers%20the%20development%20of%20a%20non-specific%20form%20of%20hypertrophy%20which%20is%20preceded%20by%20changes%20in%20cardiac%20glucose%20metabolism.%22%2C%22date%22%3A%22Sept%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.yjmcc.2021.05.016%22%2C%22ISSN%22%3A%221095-8584%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229DBYXNEE%22%2C%22VP4BFI3C%22%5D%2C%22dateModified%22%3A%222023-01-19T19%3A22%3A34Z%22%7D%7D%5D%7D
Taegtmeyer, H., Ganim, J. and Leuppi-Taegtmeyer, A. B. (2023). Hermann (“Hugh”) Blaschko (1900 - 1993) father of catecholamine metabolism. Cardiology. https://doi.org/10.1159/000528895.
Gutierrez, A. D., Gao, Z., Hamidi, V. et al. (2022). Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes. Cell Rep Med 3, 100813. https://doi.org/10.1016/j.xcrm.2022.100813.
Ashraf, S., Taegtmeyer, H. and Harmancey, R. (2022). Prolonged cardiac NR4A2 activation causes dilated cardiomyopathy in mice. Basic Res Cardiol 117, 33. https://doi.org/10.1007/s00395-022-00942-7.
Karlstaedt, A. and Taegtmeyer, H. (2022). Cardio-onco-metabolism - metabolic vulnerabilities in cancer and the heart. J Mol Cell Cardiol 171, 71–80. https://doi.org/10.1016/j.yjmcc.2022.06.008.
Thomas, S. S., Wu, J., Davogustto, G. et al. (2022). SIRPα mediates IGF1 receptor in cardiomyopathy-induced by chronic kidney disease. Circ Res, 101161CIRCRESAHA121320546. https://doi.org/10.1161/CIRCRESAHA.121.320546.
Taegtmeyer, H., Zaha, V. G. and McGuire, D. K. (2022). 2022 Beijing Winter Olympics: Spotlight on cardiac metabolism. Circulation 145, 1561–1562. https://doi.org/10.1161/CIRCULATIONAHA.122.059905.
Huang Lucas, C. and Taegtmeyer, H. (2022). Letter by Lucas and Taegtmeyer regarding article, “One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction.” Circulation 145, e642–e643. https://doi.org/10.1161/CIRCULATIONAHA.121.058145.
Haidar, A. and Taegtmeyer, H. (2022). Strategies for imaging metabolic remodeling of the heart in obesity and heart failure. Curr Cardiol Rep. https://doi.org/10.1007/s11886-022-01650-3.
Farr, M. (2021). A foot soldier in cardiac metabolism: A conversation with Heinrich Taegtmeyer, MD, DPhil. Circulation 144, 1659–1663. https://doi.org/10.1161/CIRCULATIONAHA.121.058019.
Davogustto, G. E., Salazar, R. L., Vasquez, H. G. et al. (2021). Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy. J Mol Cell Cardiol 158, 115–127. https://doi.org/10.1016/j.yjmcc.2021.05.016.